---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-035028"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2024-09-05T23:59:59+00:00"
generated_at: "2026-05-31T06:15:52.014334+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Serina Therapeutics to present at H.C. Wainwright conference on Sept 11

## Summary
- Interim CEO Steve Ledger to present at H.C. Wainwright 26th Annual Global Investment Conference.
- Presentation scheduled for September 11, 2024 at 12:00 p.m. ET.
- Live webcast available via Investor section of Serina's website; replay available for limited time.
- Serina is a clinical-stage biotech developing POZ Platform drug delivery technology.

## SEC filing metadata
- accession: 0001493152-24-035028
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2024-09-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315224035028/0001493152-24-035028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315224035028/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-035028
- JSON: https://secwatch.observer/filing/0001493152-24-035028.json
- Plain text: https://secwatch.observer/filing/0001493152-24-035028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.